Neuromodulation in COVID-19 Patients

NCT04808284 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DEVICE: Transcranial direct-current stimulation
DEVICE: Transcranial direct-current stimulation
DEVICE: Sham Transcranial direct-current stimulation

Sponsor

D'Or Institute for Research and Education

Collaborators

[object Object]
[object Object]
[object Object]